Bassam Hallis

Salisbury, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications

The impact of ethnicity on longitudinal humoral and cellular immune responses to SARS-CoV-2 booster vaccination.

The impact of ethnicity on longitudinal humoral and cellular immune responses to SARS-CoV-2 booster vaccination.

Journal: Scientific reports
Published: February 23, 2026

Reactogenicity and immunogenicity following heterologous and homologous third dose COVID-19 vaccination in UK adolescents (Com-COV3): A randomised controlled non-inferiority trial.

Reactogenicity and immunogenicity following heterologous and homologous third dose COVID-19 vaccination in UK adolescents (Com-COV3): A randomised controlled non-inferiority trial.

Journal: The Journal of infection
Published: May 27, 2025

Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: Results from COV-BOOST trial.

Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: Results from COV-BOOST trial.

Journal: The Journal of infection
Published: March 11, 2025

Estimating neutralising antibody responses against emerging SARS-CoV-2 variants utilising convalescent sera before the roll-out of XBB-lineage vaccines.

Estimating neutralising antibody responses against emerging SARS-CoV-2 variants utilising convalescent sera before the roll-out of XBB-lineage vaccines.

Journal: Vaccine
Published: November 15, 2024

Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of response.

Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of response.

Journal: The Lancet. Microbe
Published: September 25, 2024

Evaluation of a multiplexed immunoassay for assessing long-term humoral immunity Orthopoxviruses.

Evaluation of a multiplexed immunoassay for assessing long-term humoral immunity Orthopoxviruses.

Journal: Vaccine
Published: August 17, 2024

Assessment of MpoxPlex, a high-throughput and multiplexed immunoassay: a diagnostic accuracy study.

Assessment of MpoxPlex, a high-throughput and multiplexed immunoassay: a diagnostic accuracy study.

Journal: The Lancet. Microbe
Published: August 15, 2024

Comparison of assays used to detect antibody response in COVID-19 vaccine trials: Results from of a UK multi-Centre randomised controlled trial to determine the immunogenicity responses of COVID-19 vaccines administered concomitantly with seasonal influenza vaccines (ComFluCOV).

Comparison of assays used to detect antibody response in COVID-19 vaccine trials: Results from of a UK multi-Centre randomised controlled trial to determine the immunogenicity responses of COVID-19 vaccines administered concomitantly with seasonal influenza vaccines (ComFluCOV).

Journal: Vaccine
Published: May 30, 2024

Variant-specific neutralising antibodies levels induced by the PHH-1 V SARS-CoV-2 vaccine (Bimervax®) by HIPRA.

Variant-specific neutralising antibodies levels induced by the PHH-1 V SARS-CoV-2 vaccine (Bimervax®) by HIPRA.

Journal: Vaccine
Published: May 24, 2024

Interlaboratory comparison of a multiplex immunoassay that measures human serum IgG antibodies against six-group B streptococcus polysaccharides.

Interlaboratory comparison of a multiplex immunoassay that measures human serum IgG antibodies against six-group B streptococcus polysaccharides.

Journal: Human vaccines & immunotherapeutics
Published: April 12, 2024

Detection of SARS-CoV-2 BA.2.86 by lateral flow devices.

Detection of SARS-CoV-2 BA.2.86 by lateral flow devices.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: November 06, 2023

Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis.

Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis.

Journal: The Lancet. Microbe
Published: July 28, 2023
Showing 1-12 of 66

Last Updated: 09/26/2026